PACS Group director sells 63,680 shares in plan
PACS Group, Inc. director and executive vice chair Mark Hancock reported two open-market sales of common stock on June 17, 2026 totaling 63,680 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PACS Group, Inc. director and executive vice chair Mark Hancock reported two open-market sales of common stock on June 17, 2026 totaling 63,680 shares. The shares were sold at weighted average prices of $35.2838 and $35.7491 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. After these transactions, Hancock directly holds about 54.3 million shares of PACS Group common stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 60,364 | $35.2838 | $2.13M |
| Sale | Common Stock | 3,316 | $35.7491 | $119K |
Footnotes (3)
- F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
- F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $34.6757 to $35.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $35.6799 to $36.0685 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
open-market sale financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PACS (PACS) report for Mark Hancock?
Was the PACS (PACS) insider sale under a Rule 10b5-1 plan?
How are the PACS (PACS) sale prices described in the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.